In this article, Laurence Banville comments on a recent medical advice column which referenced Low T lawsuits and risks to men.In a recent advice column in the St. Louis Post-Dispatch, Dr. Keith Roach provides his advice regarding low testosterone drugs and low t lawsuits. As with many of the men currently using low t treatments, the man writing in to ‘ask Dr. Roach’ a medical question indicates that he gets weekly testosterone injections despite semi-annual blood work that comes back as normal.
The Specific Case
This 62-year-old male has reached out to testosterone only because he began to notice that he would lose his temper more easily with the people around him. The patient, however, has become increasingly concerned because of recent allegations connecting low t drugs with serious health risks, including heart attacks and strokes. He noted that his doctor placed him on Arimidex in order to keep his estrogen level low, believing that this would make the testosterone injections more safe.
The Advice Regarding Low T Treatments
According to the response of Dr. Keith Roach, low testosterone therapy should only be used with men who have consistently low testosterone levels and who are struggling with symptoms because of those levels. He indicates that testosterone “isn’t appropriate for healthy men who have a single borderline or low testosterone level without significant symptoms.”
This statement is much in line with the FDA’s last announcement regarding low t therapies, stating that the drugs were approved for diagnosable conditions. Many patients, however, are taking the medication for general symptoms associated with aging. Side effects of aging that are considered normal and common can include decreased sex drive, decrease of bone or muscle mass, increase in irritability or mood swings, and fatigue.
Dr. Roach recommended thinking twice before beginning testosterone treatments to make sure they are appropriate, and many others who have now suffered heart attacks, blood clots, strokes, and even death would agree.
The Low Testosterone Lawsuits
While the risks of testosterone are still being comprehensively studied with mixed results, 2,500 lawsuits have been filed against low t manufacturers in court. These filings have been compiled to form a multidistrict litigation (MDL) which is being presided over by the Honorable Judge Matthew F. Kennelly in Chicago. This specific case is MDL 2545.The claims of the plaintiffs have much in common, siting aggressive and misleading marketing as well as increased risk of serious health problems.
Defendants involved include many large pharmaceutical low testosterone manufacturers, the first of which to be reviewed in court is AbbVie, Inc., who produces AndroGel, the most popular low t drug currently on the market. Other companies named include Abbott Laboratories, Eli Lilly, and Endo Pharmaceuticals.The next case management conference regarding MDL 2545 is currently scheduled for October 15th, 2015 at 3:30pm.
How Can I Find Legal Support?
If you would like additional information on this topic or have suffered from serious health complications after being prescribed a low testosterone drug, you may be entitled to join the current litigation. Laurence Banville, Esq., of Banville Law is currently assisting individuals, and also sponsors the website LowTestosteroneCase.com, which offers more information and support surrounding this issue.
To speak with Laurence Banville, Esq. directly, call 917-809-6595 anytime.